Phase I/IIa Study of Combination Chemotherapy with CKD-602 and Cisplatin in Patients with Recurrent Epithelial Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I/IIa Study of Combination Chemotherapy with CKD-602 and Cisplatin in Patients with Recurrent Epithelial Ovarian Cancer

Published:2009-08 Issue:1 Volume:1171 Page:627-634
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

Kim Hee Seung,Kang Sok-Bom,Seo Sang-Soo,Han Seung-Su,Kim Jae Weon,Park Noh-Hyun,Kang Soon-Beom,Lee Hyo-Pyo,Song Yong Sang

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Reference21 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J. Clin.,2006

2. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study;Ozols;J. Clin. Oncol.,2003

3. Optimal therapy of advanced ovarian cancer: cabopltina and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5;Bookman;J. Gynecol. Cancer,2003

4. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin;Markman;J. Clin. Oncol.,1991

5. Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxel;Shapiro;Gynecol. Oncol.,1996

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian Cancer;International Journal of Molecular Sciences;2021-01-27

2. A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer;British Journal of Cancer;2020-09-30

3. Durable response after just one cycle of belotecan-based chemotherapy in a patient with relapsed primary peritoneal serous carcinoma;Journal of Obstetrics and Gynaecology Research;2013-09-19

4. Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer;Anti-Cancer Drugs;2012-03

5. Dose-finding design driven by efficacy in onco-hematology phase I/II trials;Statistics in Medicine;2011-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3